Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease
Yakeel T. Quiroz(Harvard University), Eric M. Reiman(Alzheimer's Association), Pierre N. Tariot(Banner Health), Pradeep Thiyyagura(Alzheimer's Association), Aaron P. Schultz(Harvard University), Claudia Muñoz(Universidad de Antioquia), Aarti R. Shah(Washington University in St. Louis), Natalia Acosta‐Baena(Ludwig-Maximilians-Universität München), Francisco Lopera(Universidad de Antioquia), Anne M. Fagan(Washington University in St. Louis), Hillary Protas(Alzheimer's Association), Dora Ramirez(Universidad de Antioquia), Margarita Giraldo(Universidad de Antioquia), Adam Fleisher(Banner Alzheimer’s Institute), Joseph F. Arboleda‐Velásquez(Massachusetts Eye and Ear Infirmary), Victoria Tirado(Hospital General Universitario Gregorio Marañón), Martha C. Muniz(Boston University), Jessica B. Langbaum(Ludwig-Maximilians-Universität München), Bradford C. Dickerson(Massachusetts General Hospital), Kewei Chen(Good Samaritan Medical Center), Reisa A. Sperling(Brigham and Women's Hospital), Gloria García(Universidad de Antioquia), Michael Brickhouse(Massachusetts General Hospital)
Cited by 131
Related Papers
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k